Bivalirudin with planned or provisional abciximab versus low-dose heparin and abciximab during percutaneous coronary revascularization: Results of the Comparison of Abciximab Complications with Hirulog for Ischemic Events Trial (CACHET)
A.Michael Lincoff; Neal S. Kleiman; Kandace Kottke-Marchant; Elizabeth S. Maierson; Kelly Maresh; Katherine E. Wolski; Eric J. Topol
- 作者A.Michael Lincoff; Neal S. Kleiman; Kandace Kottke-Marchant; Elizabeth S. Maierson; Kelly Maresh; Katherine E. Wolski; Eric J. Topol
- 卷第143卷
- 期第5期
- 印刷ISSN0002-8703
- 电子ISSN1097-6744
- 文件大小117.43KB
- 发表时间2002
- DOI10.1067/mhj.2002.122173